HIRSCHMAN ORIN 13D/13G Filings for Allena Pharmaceuticals, Inc. (ALNAQ)

HIRSCHMAN ORIN 13D and 13G filings for Allena Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-25
4:05 pm
Sale
2022-01-2513GAllena Pharmaceuticals, Inc.
ALNAQ
HIRSCHMAN ORIN0
0.000%
-4,000,000decrease
(Position Closed)
Filing
2021-01-25
4:20 pm
Purchase
2021-01-2013GAllena Pharmaceuticals, Inc.
ALNAQ
HIRSCHMAN ORIN4,000,000
8.000%
4,000,000increase
(New Position)
Filing